TBCRC 030: a phase II study of preoperative cisplatin versus paclitaxel in triple-negative breast cancer: evaluating the homologous recombination deficiency (HRD) biomarker.
Saved in:
| Title: | TBCRC 030: a phase II study of preoperative cisplatin versus paclitaxel in triple-negative breast cancer: evaluating the homologous recombination deficiency (HRD) biomarker. |
|---|---|
| Authors: | Mayer, E.L.1 Erica_Mayer@dfci.harvard.edu, Abramson, V.2, Jankowitz, R.3, Falkson, C.4, Marcom, P.K.5, Traina, T.6, Carey, L.7, Rimawi, M.8, Specht, J.9, Miller, K.10, Stearns, V.11, Tung, N.12, Perou, C.7, Richardson, A.L.11, Componeschi, K.1, Trippa, L.1, Tan-Wasielewski, Z.1, Timms, K.13, Krop, I.1, Wolff, A.C.11 |
| Source: | Annals of Oncology. Nov2020, Vol. 31 Issue 11, p1518-1525. 8p. |
| Database: | Academic Search Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 152684498 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: TBCRC 030: a phase II study of preoperative cisplatin versus paclitaxel in triple-negative breast cancer: evaluating the homologous recombination deficiency (HRD) biomarker. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Mayer%2C+E%2EL%2E%22">Mayer, E.L.</searchLink><relatesTo>1</relatesTo><i> Erica_Mayer@dfci.harvard.edu</i><br /><searchLink fieldCode="AR" term="%22Abramson%2C+V%2E%22">Abramson, V.</searchLink><relatesTo>2</relatesTo><br /><searchLink fieldCode="AR" term="%22Jankowitz%2C+R%2E%22">Jankowitz, R.</searchLink><relatesTo>3</relatesTo><br /><searchLink fieldCode="AR" term="%22Falkson%2C+C%2E%22">Falkson, C.</searchLink><relatesTo>4</relatesTo><br /><searchLink fieldCode="AR" term="%22Marcom%2C+P%2EK%2E%22">Marcom, P.K.</searchLink><relatesTo>5</relatesTo><br /><searchLink fieldCode="AR" term="%22Traina%2C+T%2E%22">Traina, T.</searchLink><relatesTo>6</relatesTo><br /><searchLink fieldCode="AR" term="%22Carey%2C+L%2E%22">Carey, L.</searchLink><relatesTo>7</relatesTo><br /><searchLink fieldCode="AR" term="%22Rimawi%2C+M%2E%22">Rimawi, M.</searchLink><relatesTo>8</relatesTo><br /><searchLink fieldCode="AR" term="%22Specht%2C+J%2E%22">Specht, J.</searchLink><relatesTo>9</relatesTo><br /><searchLink fieldCode="AR" term="%22Miller%2C+K%2E%22">Miller, K.</searchLink><relatesTo>10</relatesTo><br /><searchLink fieldCode="AR" term="%22Stearns%2C+V%2E%22">Stearns, V.</searchLink><relatesTo>11</relatesTo><br /><searchLink fieldCode="AR" term="%22Tung%2C+N%2E%22">Tung, N.</searchLink><relatesTo>12</relatesTo><br /><searchLink fieldCode="AR" term="%22Perou%2C+C%2E%22">Perou, C.</searchLink><relatesTo>7</relatesTo><br /><searchLink fieldCode="AR" term="%22Richardson%2C+A%2EL%2E%22">Richardson, A.L.</searchLink><relatesTo>11</relatesTo><br /><searchLink fieldCode="AR" term="%22Componeschi%2C+K%2E%22">Componeschi, K.</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Trippa%2C+L%2E%22">Trippa, L.</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Tan-Wasielewski%2C+Z%2E%22">Tan-Wasielewski, Z.</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Timms%2C+K%2E%22">Timms, K.</searchLink><relatesTo>13</relatesTo><br /><searchLink fieldCode="AR" term="%22Krop%2C+I%2E%22">Krop, I.</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Wolff%2C+A%2EC%2E%22">Wolff, A.C.</searchLink><relatesTo>11</relatesTo> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Annals+of+Oncology%22">Annals of Oncology</searchLink>. Nov2020, Vol. 31 Issue 11, p1518-1525. 8p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=152684498 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.annonc.2020.08.2064 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 8 StartPage: 1518 Titles: – TitleFull: TBCRC 030: a phase II study of preoperative cisplatin versus paclitaxel in triple-negative breast cancer: evaluating the homologous recombination deficiency (HRD) biomarker. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Mayer, E.L. – PersonEntity: Name: NameFull: Abramson, V. – PersonEntity: Name: NameFull: Jankowitz, R. – PersonEntity: Name: NameFull: Falkson, C. – PersonEntity: Name: NameFull: Marcom, P.K. – PersonEntity: Name: NameFull: Traina, T. – PersonEntity: Name: NameFull: Carey, L. – PersonEntity: Name: NameFull: Rimawi, M. – PersonEntity: Name: NameFull: Specht, J. – PersonEntity: Name: NameFull: Miller, K. – PersonEntity: Name: NameFull: Stearns, V. – PersonEntity: Name: NameFull: Tung, N. – PersonEntity: Name: NameFull: Perou, C. – PersonEntity: Name: NameFull: Richardson, A.L. – PersonEntity: Name: NameFull: Componeschi, K. – PersonEntity: Name: NameFull: Trippa, L. – PersonEntity: Name: NameFull: Tan-Wasielewski, Z. – PersonEntity: Name: NameFull: Timms, K. – PersonEntity: Name: NameFull: Krop, I. – PersonEntity: Name: NameFull: Wolff, A.C. IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 11 Text: Nov2020 Type: published Y: 2020 Identifiers: – Type: issn-print Value: 09237534 Numbering: – Type: volume Value: 31 – Type: issue Value: 11 Titles: – TitleFull: Annals of Oncology Type: main |
| ResultId | 1 |
